Pfizer | Michigan | multiple | 2001 | $84,200,000 | | MEGADEAL (Archived) |
Pfizer | Connecticut | multiple | 1998 | $60,000,000 | | MEGADEAL (Archived) |
Wyeth Holdings Corporation | North Carolina | state | 2008 | $18,128,934 | | tax credit/rebate |
Pharmacia & Upjohn Company | New Jersey | state | 1998 | $12,500,000 | | grant |
Pfizer | New York | local | 2003 | $10,401,000 | | tax credit/rebate; property tax abatement |
Pfizer Inc. | New Jersey | state | 2010 | $9,182,250 | | grant |
Pharmacia Corporation, Affiliates and Subsidiaries | New Jersey | state | 2001 | $8,752,000 | | grant |
King Pharmaceuticals, Inc. | New Jersey | state | 2005 | $8,253,750 | | grant |
Pfizer, Inc. | New York | local | 2007 | $5,510,432 | | tax credit/rebate; property tax abatement |
Pfizer, Inc. | Pennsylvania | state | 2011 | $5,195,497 | | tax credit/rebate |
Pfizer Central Research | Connecticut | state | 2000 | $5,000,000 | | grant |
Wyeth Holdings Corporation | North Carolina | state | 2013 | $4,097,786 | | tax credit/rebate |
Pfizer, Inc. | Pennsylvania | state | 2010 | $4,091,278 | | tax credit/rebate |
Pfizer, Inc. | New York | local | 2006 | $3,750,210 | | tax credit/rebate; property tax abatement |
Wyeth Holdings Corporation | North Carolina | state | 2014 | $3,476,438 | | tax credit/rebate |
Pfizer, Inc. | New York | local | 2005 | $3,276,473 | | tax credit/rebate; property tax abatement |
PHARMACIA CORPORATION | Missouri | state | 2002 | $3,235,374 | | tax credit/rebate |
Doral Arrowwood (Pfizer) | New York | local | 2004 | $3,137,110 | | tax credit/rebate; property tax abatement |
Hospira, Inc. and Subsidiaries | Illinois | state | 2005 | $3,000,000 | | grant |
Pfizer, Inc. | New York | state | 2003 | $2,956,000 | | enterprise zone |
Hospira, Inc. and Subsidiaries | Illinois | state | 2008 | $2,872,836 | | tax credit/rebate |
Wyeth Holdings Corporation | North Carolina | state | 2009 | $2,868,194 | | tax credit/rebate |
Pfizer, Inc. | New York | state | 2002 | $2,783,900 | | enterprise zone |
Pfizer, Inc. | Pennsylvania | state | 2009 | $2,715,300 | | tax credit/rebate |
Pfizer, Inc. | Tennessee | local | 2017 | $2,582,313 | | property tax abatement |
Hospira, Inc. | North Carolina | state | 2017 | $2,266,743 | | tax credit/rebate |
Doral Arrowwood (Pfizer) | New York | local | 2006 | $2,022,893 | | tax credit/rebate; property tax abatement |
PFIZER, INC. | Missouri | state | 2007 | $2,000,000 | | training reimbursement |
Wyeth Pharmaceuticals | Virginia | state | 2004 | $2,000,000 | | grant |
Pfizer, Inc. | New York | local | 2004 | $1,919,713 | | tax credit/rebate; property tax abatement |
Hospira, Inc. | North Carolina | state | 2004 | $1,812,000 | | grant |
Hospira, Inc. | North Carolina | state | 2018 | $1,712,426 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2010 | $1,665,848 | | tax credit/rebate |
Wyeth Holdings Corporation | North Carolina | state | 2009 | $1,653,115 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2009 | $1,617,030 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Illinois | state | 2007 | $1,385,605 | | tax credit/rebate |
Pfizer, Inc. | North Carolina | state | 2015 | $1,320,134 | | tax credit/rebate |
Pfizer Inc. | Pennsylvania | state | 2008 | $1,257,546 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Illinois | state | 2006 | $1,250,000 | | tax credit/rebate |
G.D. SEARLE & COMPANY | Missouri | state | 2002 | $1,126,728 | | tax credit/rebate |
Pfizer, Inc. | Iowa | state | 2022 | $1,098,728 | | tax credit |
Pfizer, Inc. | Iowa | state | 2023 | $1,098,728 | | tax credit |
Pfizer, Inc. | North Carolina | state | 2016 | $1,013,383 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Illinois | state | 2005 | $1,000,000 | | tax credit/rebate |
Pfizer, Inc. | Michigan | state | 2019 | $1,000,000 | | tax credit/rebate |
Pfizer Inc & Subsidiaries | Iowa | state | 2010 | $942,184 | | tax credit/rebate |
Doral/Pfizer | New York | local | 2009 | $932,710 | | tax credit/rebate; property tax abatement |
Pfizer, Inc. | New York | local | 2008 | $862,541 | | tax credit/rebate; property tax abatement |
Pfizer, Inc. | North Carolina | state | 2019 | $802,663 | | tax credit/rebate |
Wyeth | Pennsylvania | state | 2008 | $802,021 | | tax credit/rebate |
Pfizer, Inc. | North Carolina | state | 2013 | $755,362 | | tax credit/rebate |
Doral Arrowwood (Pfizer) | New York | local | 2005 | $701,075 | | tax credit/rebate; property tax abatement |
Hospira, Inc. and Subsidiaries | Illinois | state | 2008 | $668,300 | | tax credit/rebate |
Doral/Pfizer | New York | local | 2007 | $662,163 | | tax credit/rebate; property tax abatement |
Hospira inc | Kansas | state | 2013 | $650,000 | | grant |
Hospira, Inc. | North Carolina | state | 2022 | $632,089 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2015 | $623,585 | | tax credit/rebate |
Doral/Pfizer | New York | local | 2003 | $613,020 | | tax credit/rebate; property tax abatement |
Pfizer, Inc. | North Carolina | state | 2012 | $607,213 | | tax credit/rebate |
Doral/Pfizer | New York | local | 2014 | $607,052 | | tax credit/rebate |
Doral/Pfizer | New York | local | 2010 | $596,605 | | tax credit/rebate; property tax abatement |
Hospira, Inc. | North Carolina | state | 2008 | $537,281 | | tax credit/rebate |
HOSPIRA, INC. | California | state | 2009 | $536,590 | | training reimbursement |
Doral/Pfizer | New York | local | 2013 | $516,004 | | tax credit/rebate; property tax abatement |
Hospira, Inc. | North Carolina | state | 2021 | $512,192 | | tax credit/rebate |
Pfizer, Inc. | North Carolina | state | 2011 | $501,793 | | tax credit/rebate |
Wyeth-Ayerst Pharmaceuticals | Pennsylvania | state | | $500,000 | | grant |
Wyeth Pharmaceuticals, Inc. | Pennsylvania | state | | $500,000 | | grant |
Wyeth-Lederle (#2) | North Carolina | state | 2004 | $500,000 | | grant |
Pfizer, Inc. | New York | state | 2005 | $500,000 | | enterprise zone |
Pfizer, Inc. | North Carolina | state | 2018 | $495,412 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2013 | $483,750 | | grant |
Doral/Pfizer | New York | local | 2008 | $462,392 | | tax credit/rebate; property tax abatement |
HOSPIRA, INC. | California | state | 2006 | $439,595 | | training reimbursement |
Pfizer Inc., and Subsidiaries | Maryland | state | 2015 | $427,891 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2016 | $415,010 | | tax credit/rebate |
Hospira, Inc. and Subsidiaries | Illinois | state | 2007 | $404,000 | | tax credit/rebate |
Doral/Pfizer | New York | local | 2015 | $402,469 | | tax credit/rebate |
Doral/Pfizer | New York | local | 2016 | $402,469 | | tax credit/rebate |
Wyeth Holdings Corporation | North Carolina | state | 2010 | $373,801 | | tax credit/rebate |
Doral/Pfizer | New York | local | 2011 | $360,540 | | tax credit/rebate; property tax abatement |
Doral/Pfizer | New York | local | 2012 | $357,613 | | tax credit/rebate; property tax abatement |
Hospira, Inc. | North Carolina | state | 2011 | $344,981 | | tax credit/rebate |
PFIZER, INC. | Missouri | state | 2000 | $315,055 | | tax credit/rebate |
Pfizer, Inc. | North Carolina | state | 2017 | $305,389 | | tax credit/rebate |
WYETH HOLDINGS CORPORATION | New York | local | 2009 | $280,900 | | tax credit/rebate; property tax abatement |
Hospira, Inc. | North Carolina | state | 2019 | $280,119 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2016 | $277,903 | | tax credit/rebate |
Wyeth Holdings Corporation | North Carolina | state | 2013 | $272,967 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2013 | $261,281 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2008 | $254,292 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2011 | $252,000 | | tax credit/rebate |
BioRexis | Pennsylvania | state | | $250,000 | | training reimbursement |
Hospira, Inc. | North Carolina | state | 2015 | $240,137 | | tax credit/rebate |
Pfizer, Inc. | Pennsylvania | state | 2016 | $237,427 | | tax credit/rebate |
Pfizer, Inc. | North Carolina | state | 2020 | $236,439 | | tax credit/rebate |
Pfizer, Inc. | North Carolina | state | 2023 | $236,405 | | tax credit/rebate |
Pfizer Holdings Americas Corporation | North Carolina | state | 2015 | $236,159 | | tax credit/rebate |
Hospira, Inc. | North Carolina | state | 2013 | $231,735 | | tax credit/rebate |
PFIZER INC | New York | local | 2012 | $228,420 | | property tax abatement |
PFIZER INC | New York | local | 2011 | $228,375 | | property tax abatement |